Efficacy and safety of telaprevir with pegylated interferon α‐2a and ribavirin in Japanese patients

ConclusionTVR in combination with PEG‐IFNα‐2a/RBV provided a high SVR rate for the treatment of genotype 1 HCV in both treatment‐naïve and relapsed patients in Japan. TVR‐based therapy may provide a useful treatment option for patients who are difficult to treat due to NS5A (Y93, L31) and NS3/4A (D168) variants.

Source: Hepatology Research - April 6, 2016 Category: Internal Medicine Authors: Hiromitsu Kumada, Fumitaka Suzuki, Naohiro Kamiya, Madori Orihashi, Yoshiyuki Nakayasu, Ichimaro Yamada Tags: Original Article Source Type: research